In the present study, we hypothesized that blocking platelet activation with Clopidogrel (CLOP) would decrease NLRP3 inflammasome activation, renal and pulmonary injury in response to polymicrobial sepsis. The gene discussed is NLRP3; the disease is Sepsis.